-
Loading metrics
Immune complex disease in a chronic monkey study with a humanised, therapeutic antibody against CCL20 is associated with complement-containing drug aggregates
- Susan B. Laffan,
- Andrew S. Thomson,
- Shing Mai,
- Cindy Fishman,
- Takahito Kambara,
- Kiran Nistala,
- James T. Raymond,
- Shugui Chen,
- Thulasi Ramani,
-
Laura Pageon,
Roles Formal analysis
Current address: Confluence Pathology, LLC, Oakland, New Jersey, United States of America
Affiliation Envigo CRS, Inc., Princeton, New Jersey, United States of America
⨯ - Rodd Polsky,
- Mark Watkins,
- Gemma Ottolangui,
- John R. White,
- Curtis Maier,
- Michael Herdman,
- [ ... ],
-
Gerben Bouma
Roles Conceptualization, Writing – original draft, Writing – review & editing
* E-mail: gerben.x.bouma@gsk.com
Affiliations Adaptive Immunity Research Unit, GlaxoSmithKline, Stevenage, United Kingdom, Clinical Pharmacology and Experimental Medicine, GlaxoSmithKline, Stevenage, United Kingdom
⨯ - [ view all ]
- [ view less ]
http://orcid.org/0000-0002-8675-9442
Immune complex disease in a chronic monkey study with a humanised, therapeutic antibody against CCL20 is associated with complement-containing drug aggregates
- Susan B. Laffan,
- Andrew S. Thomson,
- Shing Mai,
- Cindy Fishman,
- Takahito Kambara,
- Kiran Nistala,
- James T. Raymond,
- Shugui Chen,
- Thulasi Ramani,
- Laura Pageon
x
- Published: April 23, 2020
- https://doi.org/10.1371/journal.pone.0231655